Trapping effect on a small molecular drug with vascular-disrupting agent CA4P in rodent H22 hepatic tumor model:in vivomagnetic resonance imaging and postmortem inductively coupled plasma atomic emission spectroscopy-Reference-Cited by-同舟云学术

Trapping effect on a small molecular drug with vascular-disrupting agent CA4P in rodent H22 hepatic tumor model:in vivomagnetic resonance imaging and postmortem inductively coupled plasma atomic emission spectroscopy

Published:2015-01-13 Issue:5 Volume:23 Page:436-443
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Gao Meng,Yao Nan,Huang Dejian,Jiang Cuihua,Feng Yuanbo,Li Yue,Lou Bin,Peng Fei,Sun Ziping,Ni Yicheng,Zhang Jian

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference26 articles.

1. The side effects of chemotherapeutic agents

2. Drug Delivery Systems: Entering the Mainstream

3. Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice

4. Vascular Targeting Agents as Cancer Therapeutics

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring the therapeutic efficacy of CA4P in the rabbit VX2 liver tumor using dynamic contrast-enhanced MRI;Diagnostic and Interventional Radiology;2021-09-20

2. Enhancing intratumoral biodistribution and antitumor activity of nab-paclitaxel through combination with a vascular disrupting agent, combretastatin A-4-phosphate;Cancer Chemotherapy and Pharmacology;2019-09-13

3. Synthesis and Evaluation of Diindole-Based MRI Contrast Agent for In Vivo Visualization of Necrosis;Molecular Imaging and Biology;2019-07-22

4. Targeted pharmacokinetics of polymeric micelles modified with glycyrrhetinic acid and hydrazone bond in H22 tumor-bearing mice;Journal of Biomaterials Applications;2019-04-16

5. Enhanced anticancer effect of Combretastatin A-4 phosphate when combined with vincristine in the treatment of hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2017-05